Simple Summary Cancer patients are considered a high-risk group for infectious diseases
including COVID-19. The protective effects of vaccination are unclear in oncologic patients …

Cancer patients (CPs), being immunosuppressed due to the treatment received or to the
disease itself, are more susceptible to infections and their potential complications, showing …

Background Cancer patients are considered highly vulnerable to the COVID-19 pandemic.
However, delaying cancer-specific therapies could have a deleterious effect on survival. The …

Purpose Cancer patients are at risk of severe COVID-19 infection, and vaccination is
recommended. Nevertheless, we observe a failure of COVID-19 vaccines in this vulnerable …

Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with
cancer: Cancer Cell Skip to Main Content Advertisement Cancer Cell This journal offers …

SARS-CoV-2 vaccines are effective in preventing COVID-19. Patients with cancer are at
high risk for severe COVID-19 and are appropriately prioritized for vaccination. Several …

Background It was shown that immunocompromised patients have significantly reduced
immunologic responses to COVID-19 vaccines. The immunogenicity of COVID-19 …

Patients with cancer are at increased risk of severe COVID-19 disease because of
immunosuppression caused by the cancer and/or cancer treatments (Ehmsen et al., 2021b; …

Patients with cancer are considered to be at high-risk for SARS-CoV-2 infection and severe
COVID-19 (Bakouny et al., 2020). Our ''SOAP-02''(Sars-CoV-2 fOr cAncer Patients) study has …

Cancer patients (CPs) have been identified as particularly vulnerable to SARS-CoV-2
infection, and therefore are a priority group for receiving COVID-19 vaccination. From the …